Melatonin enhances the anti-tumor effect of sorafenib via AKT/p27-mediated cell cycle arrest in hepatocarcinoma cell lines
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melatonin enhances the anti-tumor effect of sorafenib via AKT/p27-mediated cell cycle arrest in hepatocarcinoma cell lines
Authors
Keywords
-
Journal
RSC Advances
Volume 7, Issue 34, Pages 21342-21351
Publisher
Royal Society of Chemistry (RSC)
Online
2017-04-18
DOI
10.1039/c7ra02113e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myc and cell cycle control
- (2015) Gabriel Bretones et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Artemisinin inhibits tumour necrosis factor-α-induced vascular smooth muscle cell proliferationin vitroand attenuates balloon injury-induced neointima formation in rats
- (2015) Qian Cao et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- p27 Kip1 signaling: Transcriptional and post-translational regulation
- (2015) Su Su Thae Hnit et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells
- (2015) Jian-Jun Lu et al. Oncotarget
- New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma
- (2014) Antoine Galmiche et al. CANCER LETTERS
- Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
- (2014) B. Zhai et al. MOLECULAR CANCER THERAPEUTICS
- HCC therapies—lessons learned
- (2014) Marcus-Alexander Wörns et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?
- (2013) Carmen Berasain GUT
- Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma
- (2013) Yingjian Liang et al. HEPATOLOGY
- Cell cycle control across the eukaryotic kingdom
- (2013) Hirofumi Harashima et al. TRENDS IN CELL BIOLOGY
- In-vitro growth inhibition of chemotherapy and molecular targeted agents in hepatocellular carcinoma
- (2012) Alex Y. Chang et al. ANTI-CANCER DRUGS
- Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation
- (2012) Claudio Zavaglia et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells
- (2011) Ji-Hyun Kim et al. JOURNAL OF PINEAL RESEARCH
- Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21
- (2011) Yuefeng Wang et al. Nature Chemical Biology
- Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma
- (2010) Chih-Hung Hsu et al. JOURNAL OF HEPATOLOGY
- Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of Gαs and Gαq proteins
- (2010) Stephen Y. W. Shiu et al. JOURNAL OF PINEAL RESEARCH
- In vitro and in vivo antitumor activity of melatonin receptor agonists
- (2010) Lulu Mao et al. JOURNAL OF PINEAL RESEARCH
- Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity
- (2010) D.-X. Tan et al. Obesity Reviews
- Review article: the management of hepatocellular carcinoma
- (2009) R. CABRERA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death
- (2009) Vanesa Martín et al. CANCER LETTERS
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- (2009) Jorg Hartmann et al. CURRENT DRUG METABOLISM
- Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway
- (2009) Sara Casado-Zapico et al. JOURNAL OF PINEAL RESEARCH
- Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
- (2009) Brittney Jung-Hynes et al. JOURNAL OF PINEAL RESEARCH
- Sorafenib for the treatment of hepatocellular carcinoma across geographic regions
- (2009) Chiun Hsu et al. Expert Review of Clinical Pharmacology
- Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels
- (2008) D. Morishita et al. CANCER RESEARCH
- SnapShot: Cell-Cycle Regulators I
- (2008) David O. Morgan CELL
- SnapShot: Ras Signaling
- (2008) Megan Cully et al. CELL
- Melatonin protects against endosulfan-induced oxidative tissue damage in rats
- (2008) Gülden Z. Omurtag et al. JOURNAL OF PINEAL RESEARCH
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- p27Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes
- (2008) A. Ray et al. MOLECULAR AND CELLULAR BIOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now